Fazamorexant
- Generic Name
- Fazamorexant
Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-05-16
- Target Recruit Count
- 60
- Registration Number
- NCT06975514
- Locations
- 🇨🇳
Beijing HuiLongGuan Hospital, Beijing, China
🇨🇳Peking University People's Hospital, Beijing, China
🇨🇳ChengDu Second People's Hospital, Chengdu, China
PK/PD Study of YZJ-1139
- First Posted Date
- 2024-11-12
- Last Posted Date
- 2024-11-12
- Target Recruit Count
- 20
- Registration Number
- NCT06685341
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Capital Medical University, Beijing, China
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2025-02-10
- Target Recruit Count
- 104
- Registration Number
- NCT06673927
- Locations
- 🇨🇳
Beijing Ditan Hospital Capital Medical University, Beijing, China
Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Mild, Moderate and Normal Hepatic Impairment
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-04
- Target Recruit Count
- 24
- Registration Number
- NCT06671509
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Severe Renal Impairment and Normal Renal Impairment
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-04
- Target Recruit Count
- 16
- Registration Number
- NCT06671444
- Locations
- 🇨🇳
Zhongda Hospital Southeast University, Nanjing, Jiangsu, China
🇨🇳The First Affiliated Hospital of Bengbu Medical University, Bengbu, China
🇨🇳The First Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath